Proton MR Spectroscopy in the Evaluation of Cerebral Metabolism in Patients with Fibromyalgia: Comparison with Healthy Controls and Correlation with Symptom Severity

References

1. ↵
   Wolfe F, Ross K, Anderson J, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19–28

   CrossRefPubMedWeb of Science
2. ↵
   Lautenbacher S, Rollman GB, McCain GA. Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain 1994;59:45–53

   CrossRefPubMed
3. Kosek E, Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 1997;70:41–51

   CrossRefPubMedWeb of Science
4. ↵
   Petzke F, Clauw DJ, Ambrose K, et al. Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain 2003;105:403–13

   CrossRefPubMedWeb of Science
5. ↵
   Arroyo JF, Cohen ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 1993;20:1925–31

   PubMedWeb of Science
6. ↵
   Lorenz J. Hyperalgesia or hypervigilance? An evoked potential approach to the study of fibromyalgia syndrome. Z Rheumatol 1998;57 Suppl 2:19–22

   CrossRefPubMedWeb of Science
7. ↵
   Jones AK, Brown WD, Friston KJ, et al. Cortical and subcortical localization of response to pain in man using positron emission tomography. Proc R Soc Lond B Biol Sci 1991;244:39–44

   PubMed
8. Derbyshire SW. Imaging the brain in pain. American Pain Society (APS) Bulletin 1999;9[3]:7–8
9. ↵
   Aziz Q, Thompson DG, Ng VW, et al. Cortical processing of human somatic and visceral sensation. J Neuroscience 2000;20:2657–63

   Abstract/FREE Full Text
10. ↵
    Mountz JM, Bradley LA, Modell JG, et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38:926–38

    PubMedWeb of Science
11. ↵
    Kwiatek R, Barnden L, Tedman R, et al. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 2000;43:2823–33

    CrossRefPubMedWeb of Science
12. ↵
    Gracely RH, Petzke F, Wolf JM, et al. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46:1333–43

    CrossRefPubMedWeb of Science
13. ↵
    Cook DB, Lange G, Ciccone DS, et al. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol 2004;31:364–78

    Abstract/FREE Full Text
14. ↵
    Giesecke T, Gracely RH, Grant MA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 2004;50:613–23

    CrossRefPubMedWeb of Science
15. ↵
    Ross AJ, Sachdev PS. Magnetic resonance spectroscopy in cognitive research. Brain Res Brain Res Rev 2004;44:83–102

    CrossRefPubMedWeb of Science
16. ↵
    Grachev ID, Fredrickson BE, Apkarian AV. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain 2000;89:7–18

    CrossRefPubMedWeb of Science
17. ↵
    Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–72

    CrossRefPubMedWeb of Science
18. ↵
    Petzke F, Khine A, Williams D, et al. Dolorimetry performed at 3 paired tender points highly predicts overall tenderness. J Rheumatol 2001;28:2568–69

    FREE Full Text
19. ↵
    Petzke F, Harris RE, Williams DA, et al. Differences in unpleasantness induced by experimental pressure between patients with fibromyalgia and controls. Eur J Pain 2005;9:325–35

    CrossRefPubMedWeb of Science
20. ↵
    Gracely RH, Lota L, Walter DJ, et al. A multiple random staircase method of psychophysical pain assessment. Pain 1988;32:55–63

    CrossRefPubMedWeb of Science
21. ↵
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385–401

    Abstract
22. ↵
    Spielberger CD, Gorsuch RC, Lushene RE, et al. Manual for the State-Trait Anxiety Inventory (Form Y): “Self-evaluation questionnaire.” Palo Alto, Calif: Consulting Psychologists;1983 :36
23. ↵
    Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain 1983;17:33–44

    CrossRefPubMedWeb of Science
24. ↵
    Petrou M, Sundgren PC, Pang Y, et al. Manually adjusted versus vendor preset definition of metabolite boundaries: impact on proton metabolite ratios. Acad Radiol 2007;14:340–43

    CrossRefPubMed
25. ↵
    I. Olkin, ed. Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling. Stanford, Calif: Stanford University Press;1960 :278–92
26. ↵
    Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005;52:1577–84

    CrossRefPubMedWeb of Science
27. ↵
    Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1998;17:1–15
28. Maheshwari SR, Fatterpekar GM, Castillo M, et al. Proton MR spectroscopy of the brain. Semin Ultrasound CT MR 2000;21:434–51

    CrossRefPubMed
29. ↵
    Burtscher IM, Holtas S. Proton MR spectroscopy in clinical routine. J Magn Reson Imaging 2001;13:560–67

    CrossRefPubMed
30. ↵
    Bitsch A, Bruhn H, Vougioukas, V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20:1619–27

    Abstract/FREE Full Text
31. ↵
    Tartaglia MC, Narayanan S, De Stefano N, et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 2002;249:1382–90

    CrossRefPubMedWeb of Science
32. ↵
    Burtscher IM, Holtas S. Proton MR spectroscopy in brain tumors: clinical applications. Neuroradiology 2001;43:345–52

    CrossRefPubMedWeb of Science
33. Bruhn H, Frahm J, Gungel MJ, et al. Noninvasive differentiation of tumors with the use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172:541–48

    PubMedWeb of Science
34. Moller-Hartmann W, Herminghaus S, Krings T, et al. Clinical applications of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44:371–81

    CrossRefPubMedWeb of Science
35. Herminghaus S, Dierks T, Pilatus U, et al. Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data. J Neurosurg 2003;98:74–81

    PubMed
36. ↵
    Weybright P, Sundgren PC, Maly P, et al. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol 2005;185:1471–76

    CrossRefPubMedWeb of Science
37. ↵
    Laubenberger J, Haussinger D, Bayer S, et al. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times. Radiology 1996;199:805–10

    PubMedWeb of Science
38. Chang L, Ernst T. MR spectroscopy and diffusion-weighted MR imaging in focal brain lesions in AIDS. Neuroimaging Clin N Am 1997;7:409–26

    PubMed
39. ↵
    Meyerhoff DJ, Bloomer C, Cardenas V, et al. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 1999;52:995–1003

    Abstract/FREE Full Text
40. ↵
    Brooks WM, Sabet A, Sibbitt WL Jr., et al. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol 1997;24:2323–29

    PubMedWeb of Science
41. Sibbit WL Jr, Haseler LJ, Griffey RR, et al. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. AJNR Am J Neuroradiol 1997;18:1271–77

    Abstract
42. Lim MK, Suh CH, Kim HJ, et al. Systemic lupus erythematosus: brain magnetic resonance imaging and single voxel hydrogen1 MR spectroscopy. Radiology 2000;217:43–09

    PubMedWeb of Science
43. Axford JS, Howe FA, Heron C, et al. Sensitivity of quantitative(1)H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus. Ann Rheum Dis 2001;60:106–11

    Abstract/FREE Full Text
44. ↵
    Sundgren PC, Jennings J, Attwood JT, et al. MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology 2005;47:576–85

    CrossRefPubMedWeb of Science
45. ↵
    Augustine JR. Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev 1996;22:229–44

    CrossRefPubMedWeb of Science